Baxter rises after strong medical device sales drives quarterly results beat

Shares of medical device maker Baxter BAX.N rise 1.5% to $31.65

BAX reports Q1 adj. profit of 55 cents per share, surpassing analysts' average estimate of 48 cents, according to data compiled by LSEG

Co posts Q1 revenue of $2.63 billion, exceeding estimate of $2.59 billion

BAX raises the lower end of its 2025 profit forecast range to $2.47 to $2.55 per share, compared with a prior view of $2.45 to $2.55

Including session's moves, BAX stock up 9.02% YTD